8-K - Corvus Pharmaceuticals, Inc. - 5.02
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001104659-26-047735
Filing Date: 2026-04-23
Accepted: 2026-04-23 16:30:11
Documents: 11
Period of Report: 2026-04-22
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Corvus Pharmaceuticals, Inc. (Filer) CIK : 0001626971 (see all company filings) EIN. : 464670809 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 26889089 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | crvs-20260422x8k.htm iXBRL | 8-K
2 | EX-101.SCH | crvs-20260422.xsd | EX-101.SCH
3 | EX-101.LAB | crvs-20260422_lab.xml | EX-101.LAB
4 | EX-101.PRE | crvs-20260422_pre.xml | EX-101.PRE